Blog – Page 2 – Be The Cure

ALBERTA HOPE COVID-19 TRIAL LAUNCHES

With COVID-19 continuing to impact the lives of people across the world, research is vital to combat this virus. In hopes of finding an antidote, the University of Alberta and University of Calgary have partnered up to lead an investigation to see if the drug hydroxychloroquine (HCQ) may be effective in treating COVID-19. This week, […]

SODIUM-HF: Study of Dietary Intervention Under 100 MMOL in Heart Failure

Welcome! The SODIUM-HF trial is underway at many centres across Australia, Canada, Chile, Columbia, Mexico, and New Zealand. The trial will include 1,000 patients with heart failure for up to two years. The SODIUM-HF study is looking at the effects of a low-salt diet compared to usual dietary recommendations for people with heart failure. Patients […]

Diabetic Gastroparesis Treatment Study Seeks Participants

This is a global, multicenter clinical trial to test the effectiveness and safety of an investigational drug called Relamorelin for the treatment of gastroparesis in people who also have diabetes mellitus. An investigational drug is a drug that is not for sale in this country. This is a 16 week long, placebo-controlled, double-blinded study. There […]

Type 2 Diabetics Needed for a Clinical Trial Investigating a New Type of Glucose-Lowering Drug

SCORED Clinical Trial* The University of Calgary Clinical Trials Unit is currently seeking individuals with Type 2 Diabetes to participate in this clinical trial. This study investigates a new type of glucose-lowering drug that works in the kidneys to allow more sugar to be lost in the urine and intestines to prevent absorption of sugars. […]

Seeking Individuals with Type 2 Diabetes for the REMIT Study (Lifestyle Intervention)

The University of Calgary Clinical Trials Unit, at The Diabetes Hypertension and Cholesterol Center, is currently seeking individuals with Type 2 Diabetes to participate in a clinical trial called the REMIT Study. This trial is researching the effectiveness of a new approach to diabetes treatment, with the intention of inducing a remission of diabetes. This […]

A study in youth aged 12–17 is studying the effects of gut bacteria on thoughts and behaviours

Have you ever wondered how the foods you eat and the bacteria in your gut impact your thoughts and behaviours? A study at the University of Calgary is working to explore just that. Individuals ages 12-17 are being sought for a study comparing nutritional and microbiota differences between youth with obsessive-compulsive disorder (OCD) and without […]

Study for children and youth aged 7–17 with major depressive disorder

Currently, there are many medications for adult depression but very few medications for children and young people. KITES, an ADVANCE study, is an international clinical research study that will evaluate the safety and efficacy of an investigational drug in treating depression in children and youth aged 7–17. If your child or teenager has been diagnosed […]

Survey Opportunity: Shaping Senior’s Health Research by Letting Us Know What Matters to You

Older adults are the fastest growing group in the Alberta population. Within 20 years, one in five Albertans will be 65 years of age or older. Given our aging population, seniors’ health is an important issue for the healthcare system and Albertans. Seniors’ health covers a wide breadth of topics, and research studies contribute to […]

Research Participants Needed to Help with Novel Fiber and Gut Bacteria Study!

Our FYBER research group at the U of A is looking for research participants to help with our new and innovative gut bacteria and fibre study. We are interested in seeing how a dietary fibre supplement will impact our health through improving the health of our gut microbes. We will ask you to add a […]

ACCESS Trial aims to improve the health of low-income seniors

When you live with a chronic disease, bills from costly medications can add up. Investigators from the University of Calgary want to see this change and created the ACCESS Trial as a result. The purpose of the ACCESS Trial is to determine whether providing selected high-value preventive medications and comprehensive patient education programs for free […]

« Previous 1 2 3 Next »